Clorox (CLX) Tops Q3 EPS by 10c; Lifts Outlook

Go back to Clorox (CLX) Tops Q3 EPS by 10c; Lifts Outlook

Clorox Reports 2 Percent Sales Growth and 12 Percent EPS Growth in Q3, Updates Fiscal Year 2016 Outlook

May 3, 2016 6:30 AM EDT

OAKLAND, CA -- (Marketwired) -- 05/03/16 -- The Clorox Company (NYSE: CLX) today reported 2 percent sales growth and 12 percent growth in diluted net earnings per share (EPS) from continuing operations for its third quarter, which ended March 31, 2016. On a currency-neutral basis, third-quarter sales grew 5 percent.

"Our 2020 strategy continues to deliver strong results," said Chief Executive Officer Benno Dorer. "Increased demand-building investments, including awareness and trial support behind product innovation, drove sales increases across all of our U.S. segments and in International on a currency-neutral basis. Importantly, we continue to drive gains in... More

Clorox Announces Acquisition of Renew Life in Fast-Growing Digestive Health Category

May 3, 2016 6:29 AM EDT

OAKLAND, CA -- (Marketwired) -- 05/03/16 -- The Clorox Company (NYSE: CLX) today announced its acquisition of Renew Life, a leading brand in dietary health, with an emphasis on digestive health. Renew Life is the No. 1 brand of probiotics in the natural channel,1 with a steadily growing share in the food, drug, and mass channel.

"For more than 100 years, the Clorox portfolio has been firmly rooted in health and wellness, first through the disinfecting properties of bleach, and later extending into Brita and Burt's Bees to meet... More